ZOETIS INC (ZTS) Stock Price, Quote, News and Overview
NYSE:ZTS - New York Stock Exchange, Inc. - US98978V1035 - Common Stock - Currency: USD
ZTS Quote, Performance and Key Statistics
160.46
+3.04 (+1.93%)
The current stock price of ZTS is 160.46 USD. In the past month the price decreased by -3.89%. In the past year, price decreased by -18.63%.
ZTS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 67.21 | 829.40B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 27.53 | 390.99B | ||
| JNJ | JOHNSON & JOHNSON | 16.25 | 390.76B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 20.56 | 230.17B | ||
| MRK | MERCK & CO. INC. | 11.71 | 226.40B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.77 | 215.98B | ||
| PFE | PFIZER INC | 8.46 | 149.04B | ||
| SNY | SANOFI-ADR | 13.62 | 136.54B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.97 | 113.23B | ||
| GSK | GSK PLC-SPON ADR | 7.81 | 74.77B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.95 | 44.58B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.15 | 19.69B |
Related stock screener links
About ZTS
Company Profile
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The company is headquartered in Parsippany, New Jersey and currently employs 14,100 full-time employees. The company went IPO on 2013-02-01. The firm is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The firm operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. The company directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The company is engaged in commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
Company Info
ZOETIS INC
10 Sylvan Way
Parsippany NEW JERSEY 07054 US
CEO: Kristin C. Peck
Employees: 14100
Company Website: https://www.zoetis.com/
Investor Relations: https://investor.zoetis.com
Phone: 19738227000
ZOETIS INC / ZTS FAQ
What is the stock price of ZOETIS INC today?
The current stock price of ZTS is 160.46 USD. The price increased by 1.93% in the last trading session.
What is the ticker symbol for ZOETIS INC stock?
The exchange symbol of ZOETIS INC is ZTS and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is ZTS stock listed?
ZTS stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for ZOETIS INC stock?
25 analysts have analysed ZTS and the average price target is 213.07 USD. This implies a price increase of 32.79% is expected in the next year compared to the current price of 160.46. Check the ZOETIS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ZOETIS INC worth?
ZOETIS INC (ZTS) has a market capitalization of 72.39B USD. This makes ZTS a Large Cap stock.
How many employees does ZOETIS INC have?
ZOETIS INC (ZTS) currently has 14100 employees.
What are the support and resistance levels for ZOETIS INC (ZTS) stock?
ZOETIS INC (ZTS) has a resistance level at 167.96. Check the full technical report for a detailed analysis of ZTS support and resistance levels.
Is ZOETIS INC (ZTS) expected to grow?
The Revenue of ZOETIS INC (ZTS) is expected to grow by 2.28% in the next year. Check the estimates tab for more information on the ZTS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ZOETIS INC (ZTS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ZTS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ZTS, evaluating the profitability, health, valuation and growth aspects
- ZOETIS INC (ZTS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ZOETIS INC (ZTS) Sales and EPS estimates to see what analysts future expectations are.
- ZOETIS INC (ZTS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ZOETIS INC (ZTS) Insider and Institutional Ownership to learn about the owners and their transactions.
- ZOETIS INC (ZTS) Stock Chart to make your own analysis
- ZOETIS INC (ZTS) Latest news and press-releases to stay up to date.
Does ZOETIS INC (ZTS) stock pay dividends?
ZOETIS INC (ZTS) has a dividend yield of 1.28%. The yearly dividend amount is currently 1.73. Check the full fundamental report for a detailed analysis of ZTS dividend history, reliability and sustainability.
When does ZOETIS INC (ZTS) report earnings?
ZOETIS INC (ZTS) will report earnings on 2025-04-30, before the market open.
What is the Price/Earnings (PE) ratio of ZOETIS INC (ZTS)?
The PE ratio for ZOETIS INC (ZTS) is 27.1. This is based on the reported non-GAAP earnings per share of 5.92 and the current share price of 160.46 USD. Check the full fundamental report for a full analysis of the valuation metrics for ZTS.
What is the Short Interest ratio of ZOETIS INC (ZTS) stock?
The outstanding short interest for ZOETIS INC (ZTS) is 1.91% of its float. Check the ownership tab for more information on the ZTS short interest.
ZTS Technical Analysis
ZTS Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ZTS. ZTS has an excellent profitability rating, but there are some minor concerns on its financial health.
ZTS Financial Highlights
Over the last trailing twelve months ZTS reported a non-GAAP Earnings per Share(EPS) of 5.92. The EPS increased by 11.28% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 26.86% | ||
| ROA | 17.46% | ||
| ROE | 52.12% | ||
| Debt/Equity | 1.09 |
ZTS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to ZTS. The Buy consensus is the average rating of analysts ratings from 25 analysts.
For the next year, analysts expect an EPS growth of 6.03% and a revenue growth 2.28% for ZTS